MEN1611 With Cetuximab in Metastatic Colorectal Cancer (C-PRECISE-01)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Josep Tabernero, MD, PhD
Vall d' Hebron Institute of Oncology (VHIO), Barcelona, Spain
Study ChairKOL profile →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
28 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ico - Site Paul Papin
Angers, France
- Centre Georges François Leclerc
Dijon, France
- Ico - Site René Gauducheau
Saint-Herblain, France
- Charite Universitaetsmedizin Berlin - Campus Benjamin Franklin
Berlin, Germany
- Universitaetsklinikum Carl Gustav Carus Tu Dresden
Dresden, Germany
- Asklepios Klinik Altona
Hamburg, Germany
- Klinikum Der Universitaet Muenchen Campus Grosshadern
Munich, Germany
- Klinikum Rechts Der Isar Der Tu
Munich, Germany
- Universitaetsklinikum Tuebingen
Tübingen, Germany
- Azienda Ospedaliero Universitaria San Martino
Genoa, Italy
- Azienda Socio Sanitaria Territoriale Niguarda
Milan, Italy
- Istituto Europeo Di Oncologia (ieo)
Milan, Italy
- Azienda Ospedaliero Universitaria Pisana
Pisa, Italy
- Istituto Clinico Humanitas
Rozzano, Italy
- Amsterdam University Medical Center
Amsterdam, Netherlands
- Maastricht University Medical Center
Maastricht, Netherlands
- Radboud Nijmegen
Nijmegen, Netherlands
- Erasmus Medisch Centrum
Rotterdam, Netherlands
- Examen Sp. Z O.O.
Skórzewo, Poland
- Centrum Onkologii-Instytut Im.M.Sklodowskiej Curie
Warsaw, Poland
- Hospital Universitari Vall D'Hebron
Barcelona, Spain
- Centro Integral Oncologico Clara Campal
Madrid, Spain
- Fundacion Jimenez Diaz
Madrid, Spain
- Hospital Universitario Ramon Y Cajal
Madrid, Spain
- Hospital Clinico Universitario de Valencia
Valencia, Spain
- Mayo Clinic Arizona
Phoenix, Arizona, United States
- the Oncology Institute of Hope and Innovation
Anaheim, California, United States
- Multicare Health System Institute for Research and Innovation
Tacoma, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 20 Jul 2020
- Primary completion
- 12 Jan 2024
- Completion
- 27 Feb 2024
- Last update posted
- 1 May 2025
- Registered enrollment
- 29
- Registry id
- NCT04495621
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.